Clinical Trials
15 trialsNCT02226276 2026-02-13
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
City of Hope Medical Center
Phase NA Active not recruiting
NCT02810873 2025-05-04
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Thomas Jefferson University
Phase NA Terminated
NCT00002981 2024-06-03
PET Scan in Treating Patients With Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01243333 2024-04-17
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
University of Utah
Phase NA Terminated
NCT01931709 2023-11-18
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
University of Washington
Phase NA Terminated
NCT02149173 2021-06-30
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
University of Washington
Phase NA Terminated
NCT00978874 2021-06-25
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT01004718 2021-05-18
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT01807117 2021-05-18
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT02287636 2020-02-24
PET/MRI and PET/CT in Diagnosing Younger Patients With Cancer
Case Comprehensive Cancer Center
Phase NA Completed
NCT01720602 2020-01-07
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
Phase NA Completed
NCT00852644 2018-05-11
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Boston Medical Center
Phase NA Terminated
NCT01222416 2017-07-02
PET/CT Evaluation of Treatment Response in Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT00537056 2017-06-14
Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI
Stanford University
Phase NA Completed
NCT00060008 2014-04-04
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Children's Hospital of Philadelphia
Phase NA Terminated